RxDoctor Payments Data

Mark Barros, PA

Surgical · Fairhaven, MANPI 1760586440

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Medtronic at 27.2% of the total. Reporting peaked in 2021 at $510 and has fallen 67.5% since, to $166 in 2025. Among surgical clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,644in general payments, 2019–2025

Across 36 payments — averaging $45.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$447
  • Cardiovascular Systems Inc.$419
  • Abbott$206
  • Philips North America LLC$202
  • Shockwave Medical, Inc$96
  • Silk Road Medical, Inc.$78
  • plus $197 from 4 others

What the payments were for

  • Food & beverage$1,644100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,644 in reported general payments places this provider in the 90th percentile of 312 surgical providers in Massachusetts.

See all surgical providers in Massachusetts

Medicare billing

Part B allowed, 2024
$9,465
Medicare patients
80
Services billed
98

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$8,629
XareltoRivaroxaban14$5,900
ClopidogrelClopidogrel Bisulfate112$1,379
Pantoprazole Sodium24$164
Oxycodone Hcl27$88

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$50$8,62914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 312 surgical providers in Massachusetts.

Other surgical in Fairhaven

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →